Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > September 13, 2023
Daily News
September 13, 2023
- Daiichi Sankyo Aims to Develop ADC DS-7300 beyond Current 4 Cancers: Exec
September 13, 2023
- MHLW Must Take Big Step on Drug Lags, Losses in FY2024 Reform: Official
September 13, 2023
- University Hospital Reform Report Finds Inadequate Review of High-Price Drug Use
September 13, 2023
- Respond to Wage Hikes for Medical Workers in FY2024 Reform: Ex-Minister
September 13, 2023
- Japan’s Envisaged IP Tax Relief Likely to Cover Drug Sales, METI Eyes FY2024 Rollout
September 13, 2023
- GARDP, Indian Firm Ink Deal to Expand Access to Shionogi Antibiotic
September 13, 2023
- Eisai Sets Up Digital Biz Unit to Build Dementia Ecosystem
September 13, 2023
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…